Skip to content

CeriBell, Inc. CBLL Product — Cost Of Revenue

Other product segments

Subscription
$124K

Similar metrics at other companies

Tactile Systems Technology logo
TCMDProduct — Cost Of Revenue
$15.26M+9.8%
TransMedics Group, Inc. logo
TMDXProduct — Cost Of Revenue
$24.31M+49.0%
Aeva Technologies logo
AEVAProduct — Cost Of Revenue
$3.04M+17.6%
CryoPort, Inc. logo
CYRXProduct — Cost Of Revenue
$12.14M+15.8%
Netscout Systems logo
NTCTProduct — Cost Of Revenue
$12.28M-21.6%
NOVA, Inc. logo
NOVProduct — Cost Of Revenue
$1.21B+2.0%

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s product — cost of revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s product — cost of revenue?
CeriBell, Inc. (CBLL) reported product — cost of revenue of $3.07M in Q1 2026.
How has CeriBell, Inc.'s product — cost of revenue changed year-over-year?
CeriBell, Inc.'s product — cost of revenue increased by 30.0% year-over-year, from $2.36M to $3.07M.
What does product — cost of revenue mean?
This metric captures the direct costs incurred to manufacture, assemble, and deliver the company's medical technology products to end users. It includes expenses such as raw materials, direct labor, manufacturing overhead, and shipping costs associated with the product segment. Monitoring this metric is essential for evaluating the direct profitability of the product line and the company's ability to achieve economies of scale in its manufacturing processes.